Artelo Biosciences Inc - ESG Rating & Company Profile powered by AI
Alternative corporations in the rating industry group for Artelo Biosciences Inc are shown below. This Disclosure rating covers 17 United Nations SDGs including: 'No Poverty', 'Industry, Innovation & Infrastructure' and 'Life on Land'. Jump to the end of the webpage for potential risks for Artelo Biosciences Inc based on industry, location and marketcap.
Artelo Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 4.0, social score of 8.0 and governance score of 8.0.
6.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 314 | Trulieve Cannabis Corp | 6.8 | High |
| 314 | Vicore Pharma Holding AB | 6.8 | High |
| 337 | Artelo Biosciences Inc | 6.7 | High |
| 337 | Calyxt Inc | 6.7 | High |
| 337 | CanSino Biologics Inc | 6.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Artelo Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Artelo Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Artelo Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Artelo Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Artelo Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Artelo Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Artelo Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Artelo Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Artelo Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Artelo Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Artelo Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Artelo Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Artelo Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Artelo Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Artelo Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Artelo Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Artelo Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Artelo Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.